Skip to content

Rheumatology — diagnosis and treatment CPD Module

2 CPD Hours Authors Donna Cosgrove, MPSI Reviewed By Margaret McCahill, Acting Chief Pharmacist, Bons Secours Hospital, Glasnevin, Co Dublin This module focuses on some of the many disorders in rheumatology, their effect on the patient and implications for quality of life. On completion of this module, it is expected that the candidate will have…

Read More

Rheumatologists responding to Covid-19

The specialty of rheumatology has established a registry of patients affected by Covid-19 to inform clinical practice, as doctors everywhere rapidly respond to the pandemic. Catherine Reilly reports Rheumatologists around the world have collaborated to establish the Covid-19 Global Rheumatology Registry, which will collect de-identified information on rheumatology patients who contract Covid-19 to inform clinical…

Read More

Irish Society for Rheumatolgy Autumn Meeting

ISR meeting takes holistic approach In advance of the upcoming autumn meeting of the Irish Society for Rheumatology, President Dr Sinéad Harney spoke to Catherine Reilly about the varied topics that will be discussed and the manpower deficits that continue to impact on patient waiting times The Irish Society for Rheumatology (ISR) autumn meeting takes…

Read More

Gout: Challenges and opportunities in diagnosis and management

Dr Rachel Cole and Prof Geraldine McCarthy discuss optimum gout management Case report A 72-year-old man was admitted to hospital in March 2019 with heart failure secondary to new onset atrial fibrillation. He had a past history of hypertension and chronic kidney disease (CKD) stage 3. He had had one episode of acute first metatarsophalangeal…

Read More

Clinical update on the treatment of rheumatoid arthritis

Dr Catherine Sullivan outlines the latest treatment options in rheumatoid arthritis Rheumatoid arthritis (RA) is a common inflammatory arthritis with a prevalence of 1 per cent worldwide. Left untreated it results in irreversible deformity and disability, there is also now ample evidence that delays in diagnosis and treatment results in poorer outcomes. The incidence of…

Read More

Plenty of rheum to improve

President of the Irish Society for Rheumatology (ISR) Dr Sinéad Harney spoke to Catherine Reilly ahead of the Society’s Spring Meeting and outlined some pivotal issues affecting the specialty Members of the Irish Society for Rheumatology (ISR) gathered recently in Dublin for its Spring Meeting, which is a key event in the Society’s calendar. The…

Read More

Results of study suggest siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome

The results of a study presented at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate an increased risk of acute coronary syndrome (ACS) in siblings of individuals with rheumatoid arthritis (RA), suggesting shared susceptibility between the two diseases. Recent studies have demonstrated that severity of RA is associated with the risk of ACS, suggesting…

Read More

Gout in the elderly linked to higher risk of dementia

The results of a US study presented at EULAR 2018 suggest that gout is associated with a 17-to-20 per cent higher risk of dementia in the elderly. The study included 1.23 million Medicare beneficiaries, of which 65,325 had incident dementia. In an analysis, which was adjusted for various potential confounding variables, including demographics, comorbidities and…

Read More

Combining NSAIDs and TNF inhibitors may reduce radiographic progression in ankylosing spondylitis

The results of a cohort study presented at EULAR 2018 showed that, in patients with ankylosing spondylitis (AS) taking TNF inhibitors, the addition of non-steroidal anti-inflammatory drugs (NSAIDs) was associated with significantly less radiographic progression in a dose-related manner at four years. When looking at specific NSAIDs, celecoxib in combination with TNF inhibitor use was…

Read More
Scroll To Top